NEOINTELLI
DEAD

Serial Number

87158590

Owner

NEOGENOMICS LABORATORIES, INC.

Attorney

Jennifer L. Whitelaw

Filing Date

Sep 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

NEOINTELLI Trademark

Serial Number: 87158590

NEOINTELLI is a trademark filed by NEOGENOMICS LABORATORIES, INC. on September 1, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NEOGENOMICS LABORATORIES, INC. (84 trademarks)

12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS, FL 33913

Entity Type: 03

Trademark Details

Filing Date

September 1, 2016

Registration Date

Not Registered

Published for Opposition

June 6, 2017

Goods & Services

Educational services, namely, providing on-line training courses and seminars in the fields of scientific testing and research services, human disease, human medical conditions, medical diagnostic testing services, medical research services, clinical scientific testing, and medical testing

Computer software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; computer software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis

Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes

Genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing information to others in the fields of scientific testing and research services and clinical scientific testing; providing an Internet website portal featuring scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 3, 2019 ASCK
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 4, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 3, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jan 25, 2018 EX1G
SOU EXTENSION 1 FILED
Jan 25, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 25, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 12, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 2, 2017 GNFN
FINAL REFUSAL E-MAILED
Mar 2, 2017 GNFR
FINAL REFUSAL WRITTEN
Mar 2, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2017 CRFA
ASSIGNED TO LIE
Feb 7, 2017 ALIE
ASSIGNED TO EXAMINER
Jan 30, 2017 DOCK
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2017 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 11, 2017 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 25, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 25, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 25, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Sep 9, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2016 NWOS
NEW APPLICATION ENTERED
Sep 5, 2016 NWAP